948.80 USD
↗ 0.35 (0.04%)PRE MARKET (AS OF 04:46 AM EDT)
Open?$949.38
High?$949.38
Low?$947.50
Prev. Close?$948.45
Volume?3.2K
Avg. Volume?3.3M
VWAP?$948.70
Rel. Volume?0.00x
Bid / Ask
Bid?$947.00 × 40
Ask?$949.00 × 40
Spread?$2.00
Midpoint?$948.00
Valuation & Ratios
Market Cap?845.8B
Shares Out?941.7M
Float?851.3M
Float %?90.1%
P/E Ratio?33.46
P/B Ratio?27.11
EPS?$28.35
Dividend?0.66%
Ex-Dividend?2026-05-15
News
Profile
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Themes
Employees
50.0K
Market Cap
845.8B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1970-07-09
Address
LILLY CORPORATE CTR
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.50Adequate
Quick Ratio?1.10Adequate
Cash Ratio?0.14Low
Debt/Equity?1.39Moderate
ValuationRICHLY VALUED
Score33/100
P/E?33.5PRICEY▾
P/B?27.11HIGH▾
P/S?11.71HIGH▾
P/FCF?71.5PRICEY▾
EV/EBITDA?24.4HIGH▾
EV/Sales?12.23HIGH▾
Returns & Efficiency
ROE?81.0%STRONG▾
ROA?21.7%STRONG▾
Cash Flow & Enterprise
FCF?$11.8B
Enterprise Value?$883.9B
Fundamentals ratios updated end of day